Treatment updates in myotonic disorders
Emma Matthews, Mark J. Specterman, Karlien Mul · 2026
Read Treatment updates in myotonic disorders by Emma Matthews, Mark J. Specterman, Karlien Mul (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13545122.txt.
Description
Matthews, Specterman, and Mul review how doctors treat myotonia, a fault in which muscles relax too slowly after they tighten. Their 2026 review explains that the fault comes from an overactive muscle membrane. It can stem from gene faults in muscle channels, or from the splicing faults seen in myotonic dystrophy, which also affect the rest of the body.
Symptoms range from slow eye opening to pain and trouble walking, and the review notes the social strain of a hidden problem. No cure exists, but many drugs can ease the stiffness. The authors also cover new trials of gene-based drugs for the main form of myotonic dystrophy. They close by asking how these new options may change daily care.
Catalog record
| CREATOR | Emma Matthews, Mark J. Specterman, Karlien Mul |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 25 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |